If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Phorm Awarded TRUSTe Certified Privacy Seal

21 Jan 2016 07:00

RNS Number : 5177M
Phorm Corporation Limited
21 January 2016
Β 

21 January 2016

Phorm Corporation Limited

("Phorm" or the "Company")

Β 

Phorm Awarded TRUSTe Certified Privacy Seal

Commitment to Consumer Privacy Verified by Industry-Leading Third Party

Phorm (AIM: PHRM), a leading advertising-technology company and first party data platform provider, is pleased to announce that it has achieved the TRUSTe Enterprise Privacy Certification across all of its online properties. TRUSTe, the authoritative voice in global Data Privacy Management, certifies the highest level of privacy compliance and trust by awarding those businesses that have demonstrated excellence in safely collecting audience intent data across all digital channels.

Β 

The TRUSTe Certified Privacy Seal is awarded following an in-depth audit of a company's user privacy standards and regulations, ensuring that measures are in place to protect any collected and stored data.

Β 

Phorm's CEO, Timothy Smith, commented:

Β 

"As privacy and trust command more of the marketing conversation, we as a company recognise the importance of transparency and will continue to prove our commitment to, and utilise, the industry's best practices.

Β 

"We chose to work with TRUSTe to formally verify and display the commitment to privacy and security that Phorm practices, and look forward to delivering this added value to our customers at every touch point."

Β 

TRUSTe's CEO, Chris Babel, commented:

Β 

"In pursuing TRUSTe Enterprise Privacy Certification, Phorm has taken their data privacy practices a step further. This achievement shows that they are committed to building trust by adhering to industry standards and protecting the data of their users."

Β 

-Ends-

For further information please contact:

Β 

Phorm Corporation Limited

Timothy Smith (Chief Executive Officer) +44 (0)20 3397 6001

Β 

Mirabaud Securities LLP (Broker) +44 (0)20 7321 2508

Jason Woollard

Peter Krens

Β 

Strand Hanson Limited (Nominated Adviser) +44 (0)20 7409 3494

James Harris

Matthew Chandler

James Dance

Β 

Β 

About Phorm:

Β 

Phorm is a leading advertising-technology company and first party data platform provider that enables brands and publishers to address online users with personalised content and advertising. Phorm's innovative platform delivers a more interesting online experience for the user and addressable campaign results for marketers. For more information, please visit: www.phorm.com

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
NRABMMTTMBJTTPF
Date   Source Headline
14th Apr 201610:00 amRNSUpdate and Resignation of Nominated Adviser
16th Mar 201612:37 pmRNSIssue of US$500,000 of Convertible Loan Notes
16th Mar 20167:00 amRNSIssue of US$500,000 of Convertible Loan Notes
25th Feb 20168:02 amRNSFunding Update and Statement re Suspension
25th Feb 20167:55 amRNSSuspension - Phorm Corporation Limited
4th Feb 20166:05 pmRNSFunding Update
1st Feb 20163:49 pmRNSSubscription Update, New Subscription & Loan
21st Jan 20167:00 amRNSPhorm Awarded TRUSTe Certified Privacy Seal
18th Jan 20167:00 amRNSSubscription & Operational Update
5th Jan 20162:00 pmRNSTR-1: Notification of major interest in shares
23rd Dec 20151:00 pmRNSRevised Non-Executive Director Compensation
22nd Dec 20157:00 amRNSDirectorate Change
7th Dec 20157:00 amRNSRepricing of Options
3rd Dec 201511:00 amRNSPhorm Enables Hover Rate with Insomnis Media
1st Dec 20157:00 amRNSNew Share Option Plan and Grant of Options
18th Nov 20157:00 amRNSTR-1: Notifications of Major Interests in Shares
28th Oct 20157:00 amRNSPartnering Agreement with INSOMNIS Media Limited
20th Oct 20157:00 amRNSAgreement with Causemo, Inc.
13th Oct 20157:00 amRNSPhorm Hires Chief Revenue Officer
9th Oct 20157:00 amRNSAgreement with Boston Globe Media Group
30th Sep 20151:33 pmRNSInterim Results
28th Aug 20152:38 pmRNSResult of AGM
10th Aug 20157:00 amRNSNotice of Annual General Meeting
7th Aug 20157:48 amRNSEquity fundraising of approximately £3.2 million
29th Jul 20157:02 amRNSUpdate re Board Changes
28th Jul 20157:00 amRNSLoan Agreement & Convertible Loan Note Extension
15th Jul 201511:21 amRNSBoard and Management Changes
3rd Jul 20157:00 amRNSOperational Update
2nd Jul 20157:16 amRNSDirectorate Change
30th Jun 20157:00 amRNSAnnual Financial Report
8th May 20154:00 pmRNSTR-1: Notification of major interest in shares
22nd Apr 20157:00 amRNSEquity Fundraising of £6.0 million Gross
21st Apr 20154:22 pmRNSOperational Update
16th Mar 20153:45 pmRNSDirectorate Change
25th Feb 20157:02 amRNSBoard Changes
19th Jan 20157:00 amRNSEquity fundraising of approximately £6.25 million
16th Jan 20157:21 amRNSOperational Update
8th Dec 20147:00 amRNSEquity Fundraising
28th Oct 20147:00 amRNSTR-1: Notification of major interest in shares
8th Oct 20147:00 amRNSEquity fundraising of £4.47 million
6th Oct 20147:00 amRNSOperational Update
22nd Aug 20147:05 amRNSSubscription To Raise £2.4 million
22nd Aug 20147:00 amRNSInterim Results
24th Jul 20142:31 pmRNSResult of Annual General Meeting
27th Jun 20147:30 amRNSGlobal Operations Update
27th Jun 20147:05 amRNSNotice of Annual General Meeting and Board Changes
27th Jun 20147:00 amRNSFinal Results for the Year Ended 31 December 2013
23rd Apr 20144:25 pmRNSTR-1: Notification of major interest in shares
14th Apr 201412:40 pmRNSResult of EGM
27th Mar 20147:00 amRNSProposed £10m Placing & Notice of EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.